Introduction: Anti-thrombotic, statins and antihypertensive drugs are commonly used for the management of acute ischemic stroke in Nepal but there is no evidence regarding their efficacy in our context. This study aims to explore the efficacy of these combined medications (anti-thrombotic, statins and antihypertensive drugs) in acute ischemic stroke patients for the first time and to assess the risk factors present in those patients. Methods: The study was conducted on 37 acute ischemic stroke patients admitted and treated at the Neurology Department of College of Medical Sciences-Teaching Hospital, Chitwan, Nepal and they were followed at three months (90±10 days). The initial stroke severity and functional disability were evaluated at ...
Stroke is a neurological disorder that is characterized by blockage of blood vessels. Clots are form...
Escola Paulista de Medicina Department of Internal MedicineUNIFESP, EPM, Department of Internal Medi...
BACKGROUND AND PURPOSE: Long-term daily aspirin is of benefit in the years after ischemic stroke, an...
The STARS trial (Stroke Treatment With Acute Reperfusion and Simvastatin) was conducted to demonstra...
Background: In Indian scenario, most of the cases of acute ischemic stroke are admitted and initiate...
Objectives - Statins have antioxidant, antiinflammatory, anticoagulant and profibrinolythic properti...
Objectives: To determine efficacy and tolerability of aspirin plus dipyridamole (combination) versus...
<p>Aim. To estimate in a 12-month study mortality and frequency of recurrent cardiovascular events, ...
Background: It remains unclear if intensive antiplatelet and statin treatments begun within 24–72 ho...
Aspirin in a daily dose of 160 to 300 mg initiated within 48 hours of symptom onset results in a net...
Objective To evaluate the efficacy and safety of argatroban versus aspirin plus clopidogrel in the t...
Background:Aspirin is widely used for secondary prevention after stroke. Cilostazol has shown promis...
Statins reportedly improve clinical outcomes for ischemic stroke patients. However, it is unclear wh...
Importance: Reduction of subsequent disabling stroke is the main goal of preventive treatment in the...
<p>Aim. To evaluate in open 12 month prospective, randomized study the mortality and recurrent cardi...
Stroke is a neurological disorder that is characterized by blockage of blood vessels. Clots are form...
Escola Paulista de Medicina Department of Internal MedicineUNIFESP, EPM, Department of Internal Medi...
BACKGROUND AND PURPOSE: Long-term daily aspirin is of benefit in the years after ischemic stroke, an...
The STARS trial (Stroke Treatment With Acute Reperfusion and Simvastatin) was conducted to demonstra...
Background: In Indian scenario, most of the cases of acute ischemic stroke are admitted and initiate...
Objectives - Statins have antioxidant, antiinflammatory, anticoagulant and profibrinolythic properti...
Objectives: To determine efficacy and tolerability of aspirin plus dipyridamole (combination) versus...
<p>Aim. To estimate in a 12-month study mortality and frequency of recurrent cardiovascular events, ...
Background: It remains unclear if intensive antiplatelet and statin treatments begun within 24–72 ho...
Aspirin in a daily dose of 160 to 300 mg initiated within 48 hours of symptom onset results in a net...
Objective To evaluate the efficacy and safety of argatroban versus aspirin plus clopidogrel in the t...
Background:Aspirin is widely used for secondary prevention after stroke. Cilostazol has shown promis...
Statins reportedly improve clinical outcomes for ischemic stroke patients. However, it is unclear wh...
Importance: Reduction of subsequent disabling stroke is the main goal of preventive treatment in the...
<p>Aim. To evaluate in open 12 month prospective, randomized study the mortality and recurrent cardi...
Stroke is a neurological disorder that is characterized by blockage of blood vessels. Clots are form...
Escola Paulista de Medicina Department of Internal MedicineUNIFESP, EPM, Department of Internal Medi...
BACKGROUND AND PURPOSE: Long-term daily aspirin is of benefit in the years after ischemic stroke, an...